These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
167 related articles for article (PubMed ID: 35517872)
21. Barriers to Early Diagnosis and Treatment of Familial Hypercholesterolemia: Current Perspectives on Improving Patient Care. Alonso R; Perez de Isla L; Muñiz-Grijalvo O; Mata P Vasc Health Risk Manag; 2020; 16():11-25. PubMed ID: 32021224 [TBL] [Abstract][Full Text] [Related]
22. Management of Familial Hypercholesterolemia: Current Status and Future Perspectives. Lui DTW; Lee ACH; Tan KCB J Endocr Soc; 2021 Jan; 5(1):bvaa122. PubMed ID: 33928199 [TBL] [Abstract][Full Text] [Related]
23. Familial Hypercholesterolemia-Risk-Score: A New Score Predicting Cardiovascular Events and Cardiovascular Mortality in Familial Hypercholesterolemia. Paquette M; Bernard S; Cariou B; Hegele RA; Genest J; Trinder M; Brunham LR; Béliard S; Baass A Arterioscler Thromb Vasc Biol; 2021 Oct; 41(10):2632-2640. PubMed ID: 34433300 [TBL] [Abstract][Full Text] [Related]
25. A regional analysis of payer and provider views on cholesterol management: PCSK9 inhibitors as an illustrative alignment model. McCormick D; Bhatt DL; Bays HE; Taub PR; Caldwell KA; Guerin CK; Steinhoff J; Ahmad Z; Singh R; Moreo K; Carter J; Heggen CL; Sapir T J Manag Care Spec Pharm; 2020 Dec; 26(12):1517-1528. PubMed ID: 33251993 [No Abstract] [Full Text] [Related]
26. Familial Hypercholesterolemia in the Arabian Gulf Region: Clinical results of the Gulf FH Registry. Alhabib KF; Al-Rasadi K; Almigbal TH; Batais MA; Al-Zakwani I; Al-Allaf FA; Al-Waili K; Zadjali F; Alghamdi M; Alnouri F; Awan Z; Kinsara AJ; AlQudaimi A; Almahmeed W; Sabbour H; Traina M; Atallah B; Al-Jarallah M; AlSarraf A; AlSayed N; Amin H; Altaradi H PLoS One; 2021; 16(6):e0251560. PubMed ID: 34086694 [TBL] [Abstract][Full Text] [Related]
27. Characteristics and management of 1093 patients with clinical diagnosis of familial hypercholesterolemia in Greece: Data from the Hellenic Familial Hypercholesterolemia Registry (HELLAS-FH). Rizos CV; Elisaf MS; Skoumas I; Tziomalos K; Kotsis V; Rallidis L; Garoufi A; Athyros VG; Skalidis E; Kolovou G; Koutagiar I; Papagianni M; Antza C; Katsiki N; Ganotakis E; Liberopoulos EN Atherosclerosis; 2018 Oct; 277():308-313. PubMed ID: 30270064 [TBL] [Abstract][Full Text] [Related]
28. Predicting Cardiovascular Events in Familial Hypercholesterolemia: The SAFEHEART Registry (Spanish Familial Hypercholesterolemia Cohort Study). Pérez de Isla L; Alonso R; Mata N; Fernández-Pérez C; Muñiz O; Díaz-Díaz JL; Saltijeral A; Fuentes-Jiménez F; de Andrés R; Zambón D; Piedecausa M; Cepeda JM; Mauri M; Galiana J; Brea Á; Sanchez Muñoz-Torrero JF; Padró T; Argueso R; Miramontes-González JP; Badimón L; Santos RD; Watts GF; Mata P Circulation; 2017 May; 135(22):2133-2144. PubMed ID: 28275165 [TBL] [Abstract][Full Text] [Related]
29. Management of familial hypercholesterolemia: a review of the recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia. Robinson JG J Manag Care Pharm; 2013 Mar; 19(2):139-49. PubMed ID: 23461430 [TBL] [Abstract][Full Text] [Related]
31. Developing and Optimizing Innovative Tools to Address Familial Hypercholesterolemia Underdiagnosis: Identification Methods, Patient Activation, and Cascade Testing for Familial Hypercholesterolemia. Campbell-Salome G; Jones LK; Masnick MF; Walton NA; Ahmed CD; Buchanan AH; Brangan A; Esplin ED; Kann DG; Ladd IG; Kelly MA; Kindt I; Kirchner HL; McGowan MP; McMinn MN; Morales A; Myers KD; Oetjens MT; Rahm AK; Schmidlen TJ; Sheldon A; Simmons E; Snir M; Strande NT; Walters NL; Wilemon K; Williams MS; Gidding SS; Sturm AC Circ Genom Precis Med; 2021 Feb; 14(1):e003120. PubMed ID: 33480803 [TBL] [Abstract][Full Text] [Related]
32. Genetics, Screening, and Treatment of Familial Hypercholesterolemia: Experience Gained From the Implementation of the Vietnam Familial Hypercholesterolemia Registry. Truong TH; Do DL; Kim NT; Nguyen MT; Le TT; Le HA Front Genet; 2020; 11():914. PubMed ID: 32922439 [TBL] [Abstract][Full Text] [Related]
33. Familial Hypercholesterolemia: New Horizons for Diagnosis and Effective Management. Mytilinaiou M; Kyrou I; Khan M; Grammatopoulos DK; Randeva HS Front Pharmacol; 2018; 9():707. PubMed ID: 30050433 [TBL] [Abstract][Full Text] [Related]
34. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark. Jensen HK Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167 [TBL] [Abstract][Full Text] [Related]
35. Expert and Advocacy Group Consensus Findings on the Horizon of Public Health Genetic Testing. Modell SM; Greendale K; Citrin T; Kardia SL Healthcare (Basel); 2016 Jan; 4(1):. PubMed ID: 27417602 [TBL] [Abstract][Full Text] [Related]
36. A Global Review on the Utility of Genetic Testing for Familial Hypercholesterolemia. Hendricks-Sturrup RM; Clark-LoCascio J; Lu CY J Pers Med; 2020 Apr; 10(2):. PubMed ID: 32295171 [TBL] [Abstract][Full Text] [Related]